Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,079 | -10,667 | -48,207 | -36,733 | -25,543 |
| Depreciation Amortization | 758 | 201 | 1,317 | 1,079 | 759 |
| Other Working Capital | -1,582 | -1,039 | -2,128 | 77 | -710 |
| Other Operating Activity | 2,139 | 928 | 6,654 | 3,519 | 2,330 |
| Operating Cash Flow | $-19,764 | $-10,577 | $-42,364 | $-32,058 | $-23,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,125 | 11,912 | -26,325 | -22,955 | 16,361 |
| PPE Investments | -549 | -498 | -1,312 | -1,152 | -711 |
| Investing Cash Flow | $18,576 | $11,414 | $-27,637 | $-24,107 | $15,650 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 52,343 | 4,930 | 4,930 |
| Debt Repayment | -667 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 36 | 8 | 361 | 42,612 | 111 |
| Financing Cash Flow | $-631 | $8 | $52,704 | $47,542 | $5,041 |
| Beginning Cash Position | 21,091 | 21,091 | 38,388 | 38,388 | 38,388 |
| End Cash Position | 19,272 | 21,936 | 21,091 | 29,765 | 35,915 |
| Net Cash Flow | $-1,819 | $845 | $-17,297 | $-8,623 | $-2,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,764 | -10,577 | -42,364 | -32,058 | -23,164 |
| Capital Expenditure | -549 | -498 | -1,312 | -1,152 | -711 |
| Free Cash Flow | -20,313 | -11,075 | -43,676 | -33,210 | -23,875 |